# The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

> **NCT05797103** · NA · COMPLETED · sponsor: **Dove Medical Press Ltd** · enrollment: 20 (actual)

## Conditions studied

- Bacterial Growth
- Novel Influenza A (H1N1)

## Interventions

- **DEVICE:** A novel electrolyzed water spray reduces numbers of bacteria E-coli and an attenuated human flu virus on human hands

## Key facts

- **NCT ID:** NCT05797103
- **Lead sponsor:** Dove Medical Press Ltd
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-29
- **Primary completion:** 2023-07-02
- **Final completion:** 2023-07-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05797103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05797103, "The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05797103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*